| Sharon A Reid, PT | |
|
844 Washington Rd, Suite 101, Westminster, MD 21157-6664 | |
| (410) 876-5600 | |
| (410) 876-1623 |
| Full Name | Sharon A Reid |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 42 Years |
| Location | 844 Washington Rd, Westminster, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003189879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 14623 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Sportscare And Rehab Llc | 2860440427 | 129 |
| Maryland Sportscare And Rehab Llc | 2860440427 | 129 |
News Archive
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.
During the five years before people develop the first clinically recognized signs of multiple sclerosis, they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
› Verified 3 days ago
| Provider Name | Maryland Sportscare & Rehab Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1518951995 PECOS PAC ID: 2860440427 Enrollment ID: O20151113000065 |
News Archive
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.
During the five years before people develop the first clinically recognized signs of multiple sclerosis, they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharon A Reid, PT 350 New Fidelity Ct, Garner, NC 27529-2665 Ph: (919) 258-2714 | Sharon A Reid, PT 844 Washington Rd, Suite 101, Westminster, MD 21157-6664 Ph: (410) 876-5600 |
News Archive
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.
During the five years before people develop the first clinically recognized signs of multiple sclerosis, they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
› Verified 3 days ago
Amanda Miller, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 511 Jermor Ln Ste 102, Westminster, MD 21157 Phone: 410-871-2494 | |
Pasteur Senior Consulting Services Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 174 Willis St, Westminster, MD 21157 Phone: 240-372-0614 | |
Donna Marie Herring, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 844 Washington Rd, Suite 101, Westminster, MD 21157 Phone: 410-876-5600 Fax: 410-876-1623 | |
Anitha N Rangarajan, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 686 Poole Rd # C, Westminster, MD 21157 Phone: 410-857-0808 | |
Erica Bechtol, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7 Tuc Rd Ste A, Westminster, MD 21157 Phone: 410-871-2494 Fax: 410-861-5303 | |
Javier C Pica, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 844 Washington Rd, Suite 101, Westminster, MD 21157 Phone: 410-876-5600 Fax: 410-876-1623 |